Jeremy G Chadwick
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $15.6M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 27SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 3,73057,472 held (−6%) | $78.36 | $292K | +43.4% |
| May 27SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 32457,148 held (−1%) | $79.17 | $26K | +42.0% |
| May 27SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 3,80053,348 held (−7%) | $79.39 | $302K | +41.6% |
| May 27SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 4,50048,848 held (−8%) | $80.02 | $360K | +40.5% |
| May 27SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 55148,297 held (−1%) | $80.71 | $44K | +39.3% |
| May 27SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 3,67944,618 held (−8%) | $81.50 | $300K | +37.9% |
| May 27SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 60044,018 held (−1%) | $82.08 | $49K | +36.9% |
| Apr 24SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 30061,202 held (−0%) | $90.00 | $27K | +24.9% |
| Apr 16SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 5,25161,202 held (−8%) | $90.00 | $473K | +24.9% |
| Apr 16SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,30061,202 held (−2%) | $90.00 | $117K | +24.9% |
| Apr 1SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 7,60061,202 held (−11%) | $85.38 | $649K | +31.6% |
| Apr 1SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 13,54062,302 held (−18%) | $85.41 | $1.2M | +31.6% |
| Apr 1SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,10061,202 held (−2%) | $86.05 | $95K | +30.6% |
| Mar 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 22,756129,696 held (−15%) | $76.73 | $1.7M | +46.5% |
| Mar 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 52,97576,721 held (−41%) | $77.21 | $4.1M | +45.6% |
| Mar 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 8,21468,507 held (−11%) | $78.40 | $644K | +43.4% |
| Mar 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 6,10562,402 held (−9%) | $79.87 | $488K | +40.7% |
| Mar 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,20061,202 held (−2%) | $80.05 | $96K | +40.4% |
| Mar 25SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 24,72761,202 held (−29%) | $80.26 | $2.0M | +40.0% |
| Mar 11SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 1,76592,045 held (−2%) | $82.13 | $145K | +36.9% |
| Mar 11SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 12,88279,163 held (−14%) | $83.10 | $1.1M | +35.3% |
| Mar 11SEC | KYMRKymera Therapeutics, Inc. | Sell Plan | 11,11168,052 held (−14%) | $83.72 | $930K | +34.3% |
| Mar 4SEC | KYMRKymera Therapeutics, Inc. | Sell | 54979,219 held (−1%) | $87.75 | $48K | +28.1% |
| Mar 4SEC | KYMRKymera Therapeutics, Inc. | Sell | 38378,836 held (−0%) | $88.50 | $34K | +27.0% |
| Mar 4SEC | KYMRKymera Therapeutics, Inc. | Sell | 1,10777,729 held (−1%) | $89.66 | $99K | +25.4% |
| Mar 4SEC | KYMRKymera Therapeutics, Inc. | Sell | 39477,335 held (−1%) | $84.00 | $33K | +33.8% |
| Mar 4SEC | KYMRKymera Therapeutics, Inc. | Sell | 2,01775,318 held (−3%) | $85.04 | $172K | +32.2% |
| Mar 4SEC | KYMRKymera Therapeutics, Inc. | Sell | 1,15074,168 held (−2%) | $85.78 | $99K | +31.0% |
| Mar 4SEC | KYMRKymera Therapeutics, Inc. | Sell | 35873,810 held (−0%) | $86.62 | $31K | +29.8% |
- Sell
COO Jeremy G Chadwick sold $292K of KYMR at $78.36 — pre-scheduled 10b5-1 plan sale.
- Sell
COO Jeremy G Chadwick sold $26K of KYMR at $79.17 — pre-scheduled 10b5-1 plan sale.
- Sell
COO Jeremy G Chadwick sold $302K of KYMR at $79.39 — pre-scheduled 10b5-1 plan sale.
- Sell
COO Jeremy G Chadwick sold $360K of KYMR at $80.02 — pre-scheduled 10b5-1 plan sale.
- Sell
COO Jeremy G Chadwick sold $44K of KYMR at $80.71 — pre-scheduled 10b5-1 plan sale.
- Sell
COO Jeremy G Chadwick sold $300K of KYMR at $81.50 — pre-scheduled 10b5-1 plan sale.